BR9608909A - Compound pharmaceutical composition processes to stimulate the release of growth hormone from patuitaria and increase the speed and extent of growth of animals to increase milk or wool production of animals or for diseases and use of the compound - Google Patents

Compound pharmaceutical composition processes to stimulate the release of growth hormone from patuitaria and increase the speed and extent of growth of animals to increase milk or wool production of animals or for diseases and use of the compound

Info

Publication number
BR9608909A
BR9608909A BR9608909A BR9608909A BR9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A
Authority
BR
Brazil
Prior art keywords
animals
compound
increase
growth
patuitaria
Prior art date
Application number
BR9608909A
Other languages
Portuguese (pt)
Inventor
Henning Thoegersen
Thomas Kruse Hansen
Jesper Lau
Nils Johansen Langeland
Behrend Friedrich Lundt
Kjeld Madsen
Birgit Sehested Hansen
Bernd Peschke
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9608909A publication Critical patent/BR9608909A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
BR9608909A 1995-06-22 1996-06-19 Compound pharmaceutical composition processes to stimulate the release of growth hormone from patuitaria and increase the speed and extent of growth of animals to increase milk or wool production of animals or for diseases and use of the compound BR9608909A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK71995 1995-06-22
DK137195 1995-12-04
PCT/DK1996/000266 WO1997000894A1 (en) 1995-06-22 1996-06-19 Compounds with growth hormone releasing properties

Publications (1)

Publication Number Publication Date
BR9608909A true BR9608909A (en) 1999-03-02

Family

ID=26064522

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608909A BR9608909A (en) 1995-06-22 1996-06-19 Compound pharmaceutical composition processes to stimulate the release of growth hormone from patuitaria and increase the speed and extent of growth of animals to increase milk or wool production of animals or for diseases and use of the compound

Country Status (12)

Country Link
EP (1) EP0833845A1 (en)
KR (1) KR19990028303A (en)
AU (1) AU711104B2 (en)
BR (1) BR9608909A (en)
CA (1) CA2224434A1 (en)
CZ (1) CZ287948B6 (en)
HU (1) HUP9802821A3 (en)
IL (1) IL122371A0 (en)
NO (1) NO975992L (en)
PL (1) PL186520B1 (en)
TW (1) TW458958B (en)
WO (1) WO1997000894A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3938797A (en) * 1996-08-29 1998-03-19 Novo Nordisk A/S Transdermal delivery of peptides
JP4116097B2 (en) 1997-06-20 2008-07-09 ノボ ノルディスク アクティーゼルスカブ Compounds with growth hormone releasing properties
US6127341A (en) * 1997-06-20 2000-10-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
CN1213036C (en) 1997-08-22 2005-08-03 科研制药株式会社 Novel amide derivatives
EP1047709B1 (en) 1998-01-16 2004-11-03 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6492410B1 (en) * 1998-05-12 2002-12-10 Warner-Lambert Company Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer
US6919315B1 (en) 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
DK1100824T3 (en) * 1998-06-30 2011-06-20 Helsinn Therapeutics Us Inc Compounds with growth hormone releasing properties
AU5671099A (en) 1998-08-14 2000-03-06 The Administrators Of The Tulane Eductional Fund Compounds having growth hormone releasing activity
EP1930021A3 (en) 1999-02-18 2008-06-18 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives as growth hormone secretagogues
EP1159964B1 (en) 2000-05-31 2009-10-28 Pfizer Products Inc. Use of growth hormone secretagogues for stimulating gastrointestinal motility
JP2004523534A (en) 2000-12-20 2004-08-05 ブリストル−マイヤーズ　スクイブ　カンパニー Cyclic derivatives as modulators of chemokine receptor activity
US6974836B2 (en) 2000-12-20 2005-12-13 Bristol-Myers Squibb Pharma Company Diamines as modulators of chemokine receptor activity
TWI331922B (en) 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
MX2009008574A (en) 2007-02-09 2009-12-09 Tranzyme Pharma Inc Macrocyclic ghrelin receptor modulators and methods of using the same.
EP2225226B1 (en) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Compounds and their use in a method for treatment of cancer
EP2318406B1 (en) 2008-07-17 2016-01-27 Critical Outcome Technologies, Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
CA2999435A1 (en) 2010-04-01 2011-10-06 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5767085A (en) * 1993-12-23 1998-06-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
US5798337A (en) * 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues

Also Published As

Publication number Publication date
JPH11507928A (en) 1999-07-13
CZ408197A3 (en) 1998-05-13
KR19990028303A (en) 1999-04-15
CA2224434A1 (en) 1997-01-09
PL186520B1 (en) 2004-01-30
MX9710377A (en) 1998-03-29
AU6188296A (en) 1997-01-22
AU711104B2 (en) 1999-10-07
HUP9802821A3 (en) 2000-03-28
TW458958B (en) 2001-10-11
HUP9802821A2 (en) 1999-03-29
NO975992D0 (en) 1997-12-19
CZ287948B6 (en) 2001-03-14
PL324200A1 (en) 1998-05-11
JP4173541B2 (en) 2008-10-29
NO975992L (en) 1998-02-20
WO1997000894A1 (en) 1997-01-09
IL122371A0 (en) 1998-06-15
EP0833845A1 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
BR9608909A (en) Compound pharmaceutical composition processes to stimulate the release of growth hormone from patuitaria and increase the speed and extent of growth of animals to increase milk or wool production of animals or for diseases and use of the compound
BR9611269A (en) Compound derived from the phenylacetic acid process for its preparation, composition and process against harmful animal pests or fungi and use of the compounds
BR9608956A (en) Compound pharmaceutical composition and processes to relieve pain and to prepare a compound
PT912194E (en) POLYNUCLEOTIDIAL VACCINE FORMULA PARTICULARLY AGAINST RESPIRATORY DISORDERS OF CATTLE
ATE178204T1 (en) INTRAVAGINAL DEVICE FOR ADMINISTRATION OF 17BETA-OESTRADIOL PRECURSOR
FR2729307B1 (en) USE OF ETHOXYL FATTY ACID ESTERS AS SELF-EMULSIONABLE COMPONENTS ESPECIALLY USEFUL FOR THE PREPARATION OF PHYTOSANITARY TREATMENT PRODUCTS OR MEDICINAL PRODUCTS FOR VETERINARY OR HUMAN USE
BR9608908A (en) Compound pharmaceutical composition processes to relieve pain and to prepare a compound
DE3876756T2 (en) DEVICE FOR CONTROLLED RELEASE AND ADMINISTRATION OF ACTIVE SUBSTANCES TO ANIMAL TISSUE.
BR9609670A (en) Compound processes for the preparation of the same use and processes to control fungal pests and animal pests
DE68916430T2 (en) PREPARATION OF MEDICINAL PRODUCTS FOR TREATING MASTITIS IN ANIMAL AND MAN.
BR9605907A (en) Formulation of prolonged release of an animal growth hormone and process for its preparation
ITMI951538A0 (en) PROCESS AND SYSTEM FOR THE DEHYDRATION OF FORAGE PARTICULARLY FOR THE DEHYDRATION OF ALfalfa
PT801561E (en) COMPOSITION AND METHODS FOR THE TRANSDERMIC DELIVERY OF LABOR DRUGS TO ACID
FR2748394B1 (en) APPLICATOR OF DRUGS FOR ANIMALS
BR9603012A (en) Resin composition molded product collar earring and medal for animals process to control the exudation of the active compound and use of the molded product
BR9506235A (en) Unique enanciometric compounds use the same processes for their preparation and (+) - and - (-) - 5-carbomethoxy-6-metail-2 - (((3,4-dimethoxy-2-pyridinyl) methyl) 1-h- benzimidazole or its sodium salt in its crystalline forms for inhibiting gastric acid secretion and for the treatment of inflammatory gastrointestinal diseases and pharmaceutical preparation
FI972949A (en) Pharmaceutical form for the release of collagenase into wounds and methods of its preparation
ATE316379T1 (en) OXYHUMIC ACID AND ITS USE IN THE TREATMENT OF VARIOUS DISORDERS
BR9612362A (en) Compounds suitable product for the control of animal pests or fungal oragas processes for the control of fungal pests and animals and for the preparation of compounds use of compounds and intermediate products
BR9709930A (en) Compound pharmaceutical composition use of a compound and processes for treating a human or animal individual and for preparing a compound
BR9607101A (en) Compound pharmaceutical formulation and processes to treat tumors of animals or humans and to produce a compound
BR8604290A (en) HETEROCYCLYLALKYL ESTERS OF ACIDOS-2-IMIDAZOLINOU, NICOTINICS, PROCESS FOR ITS PREPARATION, HERBICIDE COMPOSITION AND PROCESSES FOR SELECTIVE FIGHTING AND TO INHIBIT AND SUPPRESS PLANT GROWTH AND FOR DEPLOYING AND CROPPING
AU1581795A (en) Lure for facilitating the administration of drugs to certain animals, particularly dogs
BR9608780A (en) Compound processes for the preparation of compounds to control fungal pests to control animal pests composition suitable for controlling animal or fungal pests and use of the compounds
BR9200318A (en) 3-ARYL-PIRROLIDIN-2,4-DIONA DERIVED BICYCLES-REPLACED, PROCESS FOR THEIR PREPARATION, PESTICATED COMPOSITES, PROCESS FOR COMBATING ANIMAL PESTS, APPLICATION OF THE DERIVED DICTIONS, PROCESS FOR THE PREPARATION OF THE PREPARATION OF WEEDS AND PROCESS FOR THE PREPARATION OF HERBICIDIC COMPOSITIONS

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements